Literature DB >> 4426701

Inhibition by lysozyme of growth of the spherule phase of Coccidioides immitis in vitro.

M S Collins, D Pappagianis.   

Abstract

Development of mature endosporulating spherules from an endospore inoculum was markedly inhibited by human or hen egg-white (HEW) lysozyme at 5 mug/ml. Mature spherules formed in medium containing 5 mug per lysozyme per ml (3.3 x 10(-7) M) were approximately 50% smaller than control spherules. In addition, lysozyme induced a large portion of the endospore inoculum to revert to the mycelial growth phase. Increasing lysozyme concentrations to 10 or 20 mug/ml prompted a nearly complete reversion of the inoculum to the mycelial phase. Mature endosporulating spherules removed from growth medium and resuspended in a solution of human or HEW lysozyme at 18 mug/ml in distilled water prompted leakage of four to five times as much of materials absorbing maximally at 260 nm into the supernatant as untreated control spherules during 90 min of incubation. This four- to fivefold increase in nucleotide loss was evident at 4, 25, and 37 C. The permeability of 1-day-old immature spherules and 8-day-old endospores was considerably altered by lysozyme treatment of cells suspended in distilled water. Large amounts of potassium and nucleotides were rapidly lost by each type of cell when treated with 20 mug of lysozyme per ml. After 270 min of exposure to lysozyme, 98% of the immature spherules and 25% of the endospores were nonviable. Lysozyme adsorption by formalin-killed spherules in the presence of varying concentrations of calcium ion and the rapid alteration of permeability seen after lysozyme treatment suggested that the cell membrane was damaged as a result of binding lysozyme.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4426701      PMCID: PMC422996          DOI: 10.1128/iai.10.3.616-623.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines.

Authors:  H B LEVINE; J M COBB; C E SMITH
Journal:  Trans N Y Acad Sci       Date:  1960-04

2.  The inhibition of lysozyme by acidic polymers from pathogenic bacteria.

Authors:  R C SKARNES; D W WATSON
Journal:  J Bacteriol       Date:  1955-07       Impact factor: 3.490

3.  Effects of lysozyme and chitinase on the spherules of Coccidioides immitis in vitro.

Authors:  M Collins; D Pappagianis
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

4.  Phospholipid-protein interactions: membrane permeability correlated with monolayer "penetration".

Authors:  H K Kimelberg; D Papahadjopoulos
Journal:  Biochim Biophys Acta       Date:  1971-06-01

5.  Cellular responses in lungs of immunized mice to intranasal infection with Coccidioides immitis.

Authors:  D C Savage; S H Madin
Journal:  Sabouraudia       Date:  1968-02

6.  Interactions of basic proteins with phospholipid membranes. Binding and changes in the sodium permeability of phosphatidylserine vesicles.

Authors:  H K Kimelberg; D Papahadjopoulos
Journal:  J Biol Chem       Date:  1971-02-25       Impact factor: 5.157

7.  Effect of human lysozyme on gram-positive and gram-negative bacteria.

Authors:  H C Neu; J Dreyfus; R E Canfield
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

8.  Experiemental and clinical studies on muramidase (lysozyme). I. Muramidase activity of normal human blood cells and inflammatory exudates.

Authors:  H J Senn; B Chu; J O'Malley; J F Holland
Journal:  Acta Haematol       Date:  1970       Impact factor: 2.195

9.  The diagnostic value of lysozyme (muramidase) estimation in biological fluids.

Authors:  W Pruzanski; S G Saito
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

10.  Distribution of lysosomal enzymes, cationic proteins, and bactericidal substances in subcellular fractions of human polymorphonuclear leukocytes.

Authors:  I R Welsh; J K Spitznagel
Journal:  Infect Immun       Date:  1971-08       Impact factor: 3.441

View more
  10 in total

1.  Inhibition of Coccidioides immitis in vitro and enhancement of antiococcidiodial effects of amphotericin B by polymyxin B.

Authors:  S Collins; D Pappagians
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

Review 2.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

3.  Interaction of nonhuman primate peripheral blood leukocytes and Coccidioides immitis in vitro.

Authors:  L Beaman; C A Holmberg
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

4.  Serum and tissue lysozyme in leprosy.

Authors:  T H Rea; C R Taylor
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo.

Authors:  M Huppert; D Pappagianis; S H Sun; I Gleason-Jordan; M S Collins; K R Vukovich
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Purification and antimicrobial properties of three defensins from rat neutrophils.

Authors:  P B Eisenhauer; S S Harwig; D Szklarek; T Ganz; M E Selsted; R I Lehrer
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

Review 7.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

8.  Interactions between human granulocytes and Blastomyces dermatitidis.

Authors:  J W Sixbey; B T Fields; C N Sun; R A Clark; C M Nolan
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

9.  Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes.

Authors:  R I Lehrer; K M Ladra; R B Hake
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

10.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.